Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study

Anutosh Shee; Sarah Prior; Nicole Reeves; Maria Smith; Sharon Luccisano

doi:doi:10.11648/j.ijde.20190401.12

| Peer-Reviewed

Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study

Anutosh Shee, Sarah Prior, Nicole Reeves, Maria Smith, Sharon Luccisano

Published in International Journal of Diabetes and Endocrinology (Volume 4, Issue 1)

Received: 16 December 2018 Accepted: 5 January 2019 Published: 29 January 2019

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapy-multiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI). Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinic visits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used to capture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms was completed by the parents electronically using iSurvey application to secure information regarding their children’s diabetes related symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication (3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis. Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences in HRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601}, treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p = 0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the children without T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI, suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this first of its kind study. A further study with higher number of participants and the additional impact of various glucose monitoring systems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entire family.

Published in	International Journal of Diabetes and Endocrinology (Volume 4, Issue 1)
DOI	10.11648/j.ijde.20190401.12
Page(s)	6-12
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

Type 1 Diabetes Mellitus, Continuous Subcutaneous Insulin Infusion, Flexible Multiple Daily Injection, Multiple Daily Injection, Health Related Quality of Life, Paediatric Quality of life (PedsQL) Diabetes Module 3.0

References

[1]	Kalyva E, Malakonaki E. Health‐related quality of life (HRQoL) of children with type 1 diabetes mellitus (T1DM): self and parental perceptions. diabetes [Internet]. 2011; 12 (1):34–40.
[2]	Aihw. Prevalence of Type I diabetes among children aged 0-15 in Australia. 2013;(24):1–24.
[3]	Coghill D, Hodgkins P. Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls. European Child and Adolescent Psychiatry. 2015.
[4]	Nathan DM. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: Overview. Diabetes Care. 2014; 37 (1):9–16.
[5]	Szypowska A, Schwandt A, Svensson J, Shalitin S, Cardona-Hernandez R, Forsander G, et al. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry. Pediatr Diabetes. 2016; 17:38–45.
[6]	Li YLA. Quality of Life in Parents of Children with Type 1 Diabetes Receiving Insulin Treatment. [Internet]. Quality of Life in Parents of Children with Type 1 Diabetes Receiving Insulin Treatment. 2014.
[7]	Group DS. Training in flexible, intensive insulin management to enable dietary freedom in people with Type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. Diabet Med. 2003; 20 Suppl 3:4–5.
[8]	Alemzadeh R, Palma-Sisto P, Parton E, Totka J, Kirby M. Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus. Acta Diabetol. 2003; 40 (3):137–42.
[9]	MURILLO M, BEL J, CORRIPIO R, CARRERAS G, HERRERO X, MENGIBAR J-M, et al. Health-related quality of life (HRQOL) and its associated factors in children with Type 1 Diabetes Mellitus (T1DM). BMC Pediatr [Internet]. 2017; 17 (1):1–9.
[10]	Stahl A, Strassburger K, Lange K, Bachle C, Holl RW, Giani G, et al. Health-related quality of life among German youths with early-onset and long-duration type 1 diabetes. Diabetes Care. 2012 Aug; 35 (8):1736–42.
[11]	Wagner VM, Müller-Godeffroy E, Von Sengbusch S, Häger S, Thyen U. Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus. Eur J Pediatr. 2005; 164 (8):491–6.
[12]	Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL^TM in Type 1 and Type 2 Diabetes. Diabetes Care. 2003; 26 (3):631–7.
[13]	Peterson C, A˚kesson K, Hanberger L, Samuelsson U. Health-related quality of life of children with type 1 diabetes and the relation to metabolic control. Pediatr Diabetes [Internet]. 2015; 16:134.
[14]	Ahola AJ, Saraheimo M, Forsblom C, Hietala K, Sintonen H, Groop P-H. Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study). Nephrol Dial Transplant. 2010; 25 (6):1903–8.
[15]	Hesketh KD, Wake MA, Cameron FJ. Health-related quality of life and metabolic control in children with type 1 diabetes: a prospective cohort study. Diabetes Care. 2004; 27 (2):415–20.
[16]	Özyazicioğlu N, Avdal ET, Sağlam H. A determination of the quality of life of children and adolescents with type 1 diabetes and their parents. Int J Nurs Sci. 2016.
[17]	Anderson BJ, Laffel LM, Domenger C, Danne T, Phillip M, Mazza C, et al. Factors Associated With Diabetes- Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care [Internet]. 2017; 40 (8):1002–9.
[18]	Hanberger L, Ludvigsson J, Nordfeldt S. Health-related quality of life in intensively treated young patients with type 1 diabetes. PediatrDiabetes [Internet]. 2009; 10 (1399–5448 (Electronic) LA–eng PT–Journal Article PT–Research Support, Non–U.S. Gov’t SB–IM):374–81.
[19]	Birkebaek NH, Kristensen LJ, Mose AH, Thastum M. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Res Clin Pract. 2014 Dec; 106 (3):474–80.
[20]	H. G, J. C, E. H, B. S. O, T. B, I. C, et al. The switch study: The impact of continuous glucose monitoring on quality of life and treatment satisfaction [Internet]. Vol. 15, Value in Health. 2012. p. A359.
[21]	Lukacs A, Varga B, Kiss-Toth E, Soos A, Barkai L. Factors influencing the diabetes-specific health-related quality of life in children and adolescents with type 1 diabetes mellitus. J Child Health Care. 2014; 18 (3):253–60.
[22]	Petersson C, Huus K, Samuelsson U, Hanberger L, Akesson K. Use of the national quality registry to monitor health-related quality of life of children with type 1 diabetes: a pilot study. J Child Health Care. 2015; 19 (1):30–42.
[23]	Butwicka A, Fendler W, Zalepa A, Szadkowska A, Zawodniak-Szalapska M, Gmitrowicz A, et al. Psychiatric Disorders and Health Related Quality of Life in Children with Type 1 Diabetes Mellitus. Psychosomatics [Internet]. 2015; 57 (2):185–93.
[24]	Pham-Short A, Donaghue KC, Ambler G, Garnett S, Craig ME. Quality of Life in Type 1 Diabetes and Celiac Disease: Role of the Gluten-Free Diet. J Pediatr. 2016 Dec; 179:131–138.e1.
[25]	Danne T, Aman J, Schober E, Deiss D, Jacobsen JL, Friberg HH, et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care [Internet]. 2003; 26 (8):2359–64.
[26]	A. Z, P. V, S. C, A. T, E. C, A. C, et al. Injection pain and anxiety in children and adolescents with type 1 diabetes: Can an indwelling catheter (i-Port Advance) improve metabolic control and quality of life? [Internet]. Vol. 18, Diabetes Technology and Therapeutics. 2016. p. A123–4.
[27]	Nunn E, King B, Smart C, Anderson D. A randomized controlled trial of telephone calls to young patients with poorly controlled type 1 diabetes. Pediatr Diabetes [Internet]. 2006; 7 (5):254–9.
[28]	Opipari-arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabetes. 2007; 8 (6):377–83.

Cite This Article

Plain Text BibTeX RIS

APA Style

Anutosh Shee, Sarah Prior, Nicole Reeves, Maria Smith, Sharon Luccisano. (2019). Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. International Journal of Diabetes and Endocrinology, 4(1), 6-12. https://doi.org/10.11648/j.ijde.20190401.12

Copy | Download

ACS Style

Anutosh Shee; Sarah Prior; Nicole Reeves; Maria Smith; Sharon Luccisano. Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. Int. J. Diabetes Endocrinol. 2019, 4(1), 6-12. doi: 10.11648/j.ijde.20190401.12

Copy | Download

AMA Style

Anutosh Shee, Sarah Prior, Nicole Reeves, Maria Smith, Sharon Luccisano. Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. Int J Diabetes Endocrinol. 2019;4(1):6-12. doi: 10.11648/j.ijde.20190401.12

Copy | Download

@article{10.11648/j.ijde.20190401.12,
  author = {Anutosh Shee and Sarah Prior and Nicole Reeves and Maria Smith and Sharon Luccisano},
  title = {Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {4},
  number = {1},
  pages = {6-12},
  doi = {10.11648/j.ijde.20190401.12},
  url = {https://doi.org/10.11648/j.ijde.20190401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20190401.12},
  abstract = {Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapy-multiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI). Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinic visits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used to capture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms was completed by the parents electronically using iSurvey application to secure information regarding their children’s diabetes related symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication (3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis. Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences in HRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601}, treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p = 0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the children without T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI, suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this first of its kind study. A further study with higher number of participants and the additional impact of various glucose monitoring systems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entire family.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study
AU  - Anutosh Shee
AU  - Sarah Prior
AU  - Nicole Reeves
AU  - Maria Smith
AU  - Sharon Luccisano
Y1  - 2019/01/29
PY  - 2019
N1  - https://doi.org/10.11648/j.ijde.20190401.12
DO  - 10.11648/j.ijde.20190401.12
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 6
EP  - 12
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20190401.12
AB  - Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapy-multiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI). Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinic visits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used to capture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms was completed by the parents electronically using iSurvey application to secure information regarding their children’s diabetes related symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication (3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis. Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences in HRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601}, treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p = 0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the children without T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI, suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this first of its kind study. A further study with higher number of participants and the additional impact of various glucose monitoring systems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entire family.
VL  - 4
IS  - 1
ER  -

Copy | Download

Author Information

Anutosh Shee

Rural Clinical School, School of Medicine, University of Tasmania, Tasmania, Australia
Sarah Prior

Rural Clinical School, School of Medicine, University of Tasmania, Tasmania, Australia
Nicole Reeves

Rural Clinical School, School of Medicine, University of Tasmania, Tasmania, Australia
Maria Smith

Tasmanian Health Service – North West, Tasmania, Australia
Sharon Luccisano

Tasmanian Health Service – North West, Tasmania, Australia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Anutosh Shee, Sarah Prior, Nicole Reeves, Maria Smith, Sharon Luccisano. (2019). Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. International Journal of Diabetes and Endocrinology, 4(1), 6-12. https://doi.org/10.11648/j.ijde.20190401.12

Copy | Download

ACS Style

Anutosh Shee; Sarah Prior; Nicole Reeves; Maria Smith; Sharon Luccisano. Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. Int. J. Diabetes Endocrinol. 2019, 4(1), 6-12. doi: 10.11648/j.ijde.20190401.12

Copy | Download

AMA Style

Anutosh Shee, Sarah Prior, Nicole Reeves, Maria Smith, Sharon Luccisano. Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study. Int J Diabetes Endocrinol. 2019;4(1):6-12. doi: 10.11648/j.ijde.20190401.12

Copy | Download

@article{10.11648/j.ijde.20190401.12,
  author = {Anutosh Shee and Sarah Prior and Nicole Reeves and Maria Smith and Sharon Luccisano},
  title = {Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study},
  journal = {International Journal of Diabetes and Endocrinology},
  volume = {4},
  number = {1},
  pages = {6-12},
  doi = {10.11648/j.ijde.20190401.12},
  url = {https://doi.org/10.11648/j.ijde.20190401.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20190401.12},
  abstract = {Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapy-multiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI). Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinic visits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used to capture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms was completed by the parents electronically using iSurvey application to secure information regarding their children’s diabetes related symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication (3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis. Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences in HRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601}, treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p = 0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the children without T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI, suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this first of its kind study. A further study with higher number of participants and the additional impact of various glucose monitoring systems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entire family.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Parent-Reported Diabetic-Specific Health Related Quality of Life in Children Treated with Multiple Daily Injection, Continuous Subcutaneous Insulin Infusion and Flexible Multiple Daily Injection: A Comparative Study
AU  - Anutosh Shee
AU  - Sarah Prior
AU  - Nicole Reeves
AU  - Maria Smith
AU  - Sharon Luccisano
Y1  - 2019/01/29
PY  - 2019
N1  - https://doi.org/10.11648/j.ijde.20190401.12
DO  - 10.11648/j.ijde.20190401.12
T2  - International Journal of Diabetes and Endocrinology
JF  - International Journal of Diabetes and Endocrinology
JO  - International Journal of Diabetes and Endocrinology
SP  - 6
EP  - 12
PB  - Science Publishing Group
SN  - 2640-1371
UR  - https://doi.org/10.11648/j.ijde.20190401.12
AB  - Aims: This study aims to identify differences in diabetes specific health related quality of life (HRQoL) in children and adolescents with type 1 diabetes mellitus (T1D) treated with three distinct types of intensive insulin therapy-multiple daily injection (MDI), continuous subcutaneous insulin infusion (CSII) and flexible multiple daily injection (fMDI). Materials and Methods: This survey was conducted in north west Tasmania over a 6-month period, during quarterly clinic visits. A well-known, reliable and validated survey tool -Paediatric Quality of life (PedsQL) Diabetes Module 3.0 was used to capture information about the diabetic specific HRQoL in children and adolescents. The parent-proxy version of the forms was completed by the parents electronically using iSurvey application to secure information regarding their children’s diabetes related symptoms (11 items), treatment barriers (4 items), treatment adherence (7 items), worry (3 items) and communication (3 items). All de-identified information was downloaded into an excel spreadsheet and SPSS V24.0 for further analysis. Results: 34 parents completed the electronic data forms on iSurvey. There were no statistically significant differences in HRQoL among the CSII, MDI and fMDI groups as determined by one-way ANOVA in diabetes {F (2, 31) = 0.517, p = 0.601}, treatment {F (2, 31) = 0.385, p = 0.684}, worry {F (2, 31) = 0.076, p = 0.927}, and communication {F (2, 31) = 0.672, p = 0.518}. Conclusion: Although, the impact of T1D on the HRQoL in children and adolescents is higher than the children without T1D, it appears to be independent of the types of three intensive insulin therapy generally used- CSII, MDI and fMDI, suggesting type of insulin therapy may not be the major influencing factor for children’ quality of life as revealed in this first of its kind study. A further study with higher number of participants and the additional impact of various glucose monitoring systems on the HRQoL is highly recommended, which may influence the decision of right therapy suitable for the entire family.
VL  - 4
IS  - 1
ER  -

Copy | Download